Regional activation of Myosin II in cancer cells drives tumor progression via a secretory cross-talk with the immune microenvironment (2019)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.25418/crick.11365898
Type: Other